The Discounted Cash Flow (DCF) valuation of Adaptive Biotechnologies Corp (ADPT) is (29.52) USD. With the latest stock price at 17.83 USD, the upside of Adaptive Biotechnologies Corp based on DCF is -265.6%.
Based on the latest price of 17.83 USD and our DCF valuation, Adaptive Biotechnologies Corp (ADPT) is a sell. selling ADPT stocks now will result in a potential gain of 265.6%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.6% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (57.92) - (20.37) | (29.52) |
| Upside | -424.8% - -214.2% | -265.6% |